首页> 外文期刊>International Journal of Pharmaceutics >Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
【24h】

Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.

机译:渗透性壳聚糖胶囊的新颖设计,其特征在于不对称的膜结构,可原位形成输送孔。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, chitosan capsules with asymmetric membrane to induce osmotic effects and in situ formation of the delivery orifice were optimally prepared and characterized. Chitosan capsules were formed on stainless steel mold pins by dipping the pins into a chitosan solution followed by forming asymmetric structure by dipping into a quenching solution containing tripolyphosphate (TPP) to cause an ionic cross-linking reaction between the outer layer of chitosan and TPP. Factors influencing the properties of the capsule membrane, such as the molecular weight of chitosan, the dipping solution and dipping time, and the quenching solution and time, were optimized to successfully produce osmotic chitosan capsules with asymmetric membrane using chitosans that possessed different viscosities. In situ formation of a delivery orifice on the asymmetric membrane of the chitosan capsule was proven by the observation of a jet stream of chlorophyll being released from the capsule. Drugs with different solubility were selected, and a linear correlation between drug solubility and the initial drug release rate calculated from the slope of the drug release profile was used to verify that the delivery orifices that were in situ formed on the asymmetric membrane of the chitosan capsules induced by osmotic effect was responsible for the drug release. Water permeability across the optimally produced asymmetric membrane of the capsule from chitosan of 500 cps (300-700 cps) quenched with TPP for 30 min (C500/TPP30) was determined to be 1.40 x 10(-6)cm(2)h(-1)atm(-1) at 37.0+/-0.5 degrees C. The encapsulation of poorly water-soluble drugs, felodipine (FE) and nifedipine (NF), in such an asymmetric chitosan capsule was capable of creating a sufficient osmotic effect to activate the release of the drug with the addition of SLS and HPMC. The multiple regression equations of maximal release percent at 24h for FE and NF confirmed that both sodium lauryl sulfate (SLS) and hydroxypropyl methylcellulose (HPMC) positively influenced this response factor, and the effect of SLS was greater than that of HPMC.
机译:在这项研究中,以最佳方式制备并表征了具有不对称膜以诱导渗透作用和原位形成递送孔的壳聚糖胶囊。通过将销钉浸入壳聚糖溶液中,然后将其浸入含有三聚磷酸盐(TPP)的淬灭溶液中以引起壳聚糖外层和TPP之间的离子交联反应,从而在不锈钢模具销钉上形成壳聚糖胶囊。优化了影响胶囊膜性能的因素,如壳聚糖的分子量,浸渍溶液和浸渍时间,淬灭溶液和时间,以成功地使用具有不同粘度的壳聚糖成功生产出不对称膜的渗透性壳聚糖胶囊。通过观察从胶囊释放的叶绿素喷射流,证实了壳聚糖胶囊的不对称膜上原位形成递送孔。选择具有不同溶解度的药物,并使用药物溶解度和根据药物释放曲线的斜率计算的初始药物释放率之间的线性相关性来验证在壳聚糖胶囊的不对称膜上原位形成的递送孔渗透作用诱导的药物释放。经TPP淬灭30分钟(C500 / TPP30)的500 cps(300-700 cps)脱乙酰壳多糖在整个最佳产生的胶囊不对称膜上的透水度确定为1.40 x 10(-6)cm(2)h( -1)atm(-1)的温度为37.0 +/- 0.5摄氏度。在这种不对称的壳聚糖胶囊中,水溶性差的药物非洛地平(FE)和硝苯地平(NF)的封装能够产生足够的渗透作用通过添加SLS和HPMC来激活药物的释放。 FE和NF在24h时最大释放百分比的多元回归方程证实,月桂基硫酸钠(SLS)和羟丙基甲基纤维素(HPMC)均对该反应因子产生正向影响,并且SLS的影响大于HPMC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号